2019-01-10 |
2019-01-08 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
166,368
-33.5%
69.04
11,486,047
USD
|
166,368
-33.5%
|
69.04
|
11,486,047
USD
|
|
2018-11-30 |
2018-11-29 |
S
Sale
|
Denton David M
EVP and CFO
Officer
|
25,159
-98.4%
80.13
2,015,991
USD
|
25,159
-98.4%
|
80.13
|
2,015,991
USD
|
|
2018-11-16 |
2018-11-14 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
14,229
-16.8%
82.00
1,166,778
USD
|
14,229
-16.8%
|
82.00
|
1,166,778
USD
|
|
2018-10-03 |
2018-10-01 |
PS
Planned sale
|
Bisaccia Lisa
EVP and Chief HR Officer
Officer
|
13,770
-39.5%
80.00
1,101,600
USD
|
13,770
-39.5%
|
80.00
|
1,101,600
USD
|
|
2018-10-03 |
2018-10-01 |
PS
Planned sale
|
Bisaccia Lisa
EVP and Chief HR Officer
Officer
|
7,764
-26.9%
80.00
621,120
USD
|
7,764
-26.9%
|
80.00
|
621,120
USD
|
|
2018-10-03 |
2018-10-01 |
PS
Planned sale
|
Boratto Eva C
EVP, Cont & Chief Acct Officer
Officer
|
4,426
-9.6%
80.00
354,080
USD
|
4,426
-9.6%
|
80.00
|
354,080
USD
|
|
2018-09-19 |
2018-09-17 |
PS
Planned sale
|
Boratto Eva C
EVP, Cont & Chief Acct Officer
Officer
|
13,311
-24.1%
77.16
1,027,077
USD
|
13,311
-24.1%
|
77.16
|
1,027,077
USD
|
|
2018-08-29 |
2018-08-27 |
PS
Planned sale
|
Hourican Kevin
EVP & President, CVS Pharmacy
Officer
|
8,564
-70.6%
75.00
642,300
USD
|
8,564
-70.6%
|
75.00
|
642,300
USD
|
|
2018-05-07 |
2018-05-04 |
B
Purchase
|
DORMAN DAVID W
Non-Executive Director
|
24,300
+30.2%
62.22
1,511,868
USD
|
24,300
+30.2%
|
62.22
|
1,511,868
USD
|
|
2018-05-07 |
2018-05-04 |
B
Purchase
|
BROWN C DAVID II
Non-Executive Director
|
10,000
+11.0%
61.99
619,900
USD
|
10,000
+11.0%
|
61.99
|
619,900
USD
|
|
2018-02-21 |
2018-02-16 |
S
Sale
|
Foulkes Helena
EVP & President-CVS Pharmacy
Officer
|
19,965
-30.7%
71.04
1,418,314
USD
|
19,965
-30.7%
|
71.04
|
1,418,314
USD
|
|
2017-12-22 |
2017-12-21 |
PS
Planned sale
|
Bisaccia Lisa
EVP and Chief HR Officer
|
29,445
-65.4%
75.00
2,208,375
USD
|
29,445
-65.4%
|
75.00
|
2,208,375
USD
|
|
2017-10-03 |
2017-10-02 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
|
20,547
-47.6%
81.17
1,667,771
USD
|
20,547
-47.6%
|
81.17
|
1,667,771
USD
|
|
2017-09-19 |
2017-09-18 |
PS
Planned sale
|
Roberts Jonathan C
EVP & Chief Operating Officer
|
85,743
-71.7%
83.14
7,128,673
USD
|
85,743
-71.7%
|
83.14
|
7,128,673
USD
|
|
2017-09-19 |
2017-09-15 |
PS
Planned sale
|
Foulkes Helena
EVP & President-CVS Pharmacy
|
39,340
-46.6%
81.88
3,221,159
USD
|
39,340
-46.6%
|
81.88
|
3,221,159
USD
|
|
2017-09-15 |
2017-09-13 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
241,150
-44.6%
83.07
20,032,331
USD
|
241,150
-44.6%
|
83.07
|
20,032,331
USD
|
|
2017-09-12 |
2017-09-11 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
|
49,174
-62.9%
79.61
3,914,742
USD
|
49,174
-62.9%
|
79.61
|
3,914,742
USD
|
|
2017-09-12 |
2017-09-11 |
PS
Planned sale
|
Moriarty Thomas M
EVP & General Counsel
|
41,093
-58.6%
79.61
3,271,414
USD
|
41,093
-58.6%
|
79.61
|
3,271,414
USD
|
|
2017-09-12 |
2017-09-11 |
PS
Planned sale
|
Denton David M
EVP and CFO
|
108,183
-75.0%
79.62
8,613,530
USD
|
108,183
-75.0%
|
79.62
|
8,613,530
USD
|
|
2017-09-12 |
2017-09-11 |
PS
Planned sale
|
Denton David M
EVP and CFO
|
105,040
-74.4%
79.68
8,369,587
USD
|
105,040
-74.4%
|
79.68
|
8,369,587
USD
|
|
2017-09-12 |
2017-09-11 |
PS
Planned sale
|
Denton David M
EVP and CFO
|
23,855
-14.5%
79.61
1,899,097
USD
|
23,855
-14.5%
|
79.61
|
1,899,097
USD
|
|
2017-08-18 |
2017-08-16 |
S
Sale
|
SWIFT RICHARD J
|
2,500
-43.4%
79.62
199,050
USD
|
2,500
-43.4%
|
79.62
|
199,050
USD
|
|
2017-06-28 |
2017-06-26 |
PS
Planned sale
|
Foulkes Helena
EVP, President-CVS Pharmacy
|
20,333
-31.1%
80.00
1,626,640
USD
|
20,333
-31.1%
|
80.00
|
1,626,640
USD
|
|
2017-06-21 |
2017-06-19 |
PS
Planned sale
|
Foulkes Helena
EVP, President-CVS Pharmacy
|
20,332
-31.1%
76.98
1,565,157
USD
|
20,332
-31.1%
|
76.98
|
1,565,157
USD
|
|
2017-06-13 |
2017-06-12 |
PS
Planned sale
|
Denton David M
EVP and CFO
|
230,510
-58.3%
80.00
18,440,800
USD
|
230,510
-58.3%
|
80.00
|
18,440,800
USD
|
|
2017-03-22 |
2017-03-21 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
|
7,212
-9.3%
78.73
567,801
USD
|
7,212
-9.3%
|
78.73
|
567,801
USD
|
|
2017-03-22 |
2017-03-21 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
|
16,637
-17.6%
78.73
1,309,831
USD
|
16,637
-17.6%
|
78.73
|
1,309,831
USD
|
|
2017-03-20 |
2017-03-17 |
PS
Planned sale
|
Boratto Eva C
EVP, Cont & Chief Acct Officer
|
6,029
-14.5%
79.60
479,908
USD
|
6,029
-14.5%
|
79.60
|
479,908
USD
|
|
2017-03-14 |
2017-03-13 |
PS
Planned sale
|
Sussman Andrew
EVP, Clinical Services
|
7,449
-46.1%
80.40
598,900
USD
|
7,449
-46.1%
|
80.40
|
598,900
USD
|
|
2017-03-14 |
2017-03-13 |
PS
Planned sale
|
Sussman Andrew
EVP, Clinical Services
|
6,655
-29.2%
80.40
535,062
USD
|
6,655
-29.2%
|
80.40
|
535,062
USD
|
|
2017-03-13 |
2017-03-10 |
PS
Planned sale
|
Denton David M
EVP and CFO
|
95,618
-38.2%
80.68
7,714,460
USD
|
95,618
-38.2%
|
80.68
|
7,714,460
USD
|
|
2017-02-17 |
2017-02-16 |
PS
Planned sale
|
Roberts Jonathan C
EVP & President, CVS Caremark
|
61,196
-68.0%
80.00
4,895,680
USD
|
61,196
-68.0%
|
80.00
|
4,895,680
USD
|
|
2017-02-03 |
2017-02-01 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
76,494
-24.0%
78.32
5,991,010
USD
|
76,494
-24.0%
|
78.32
|
5,991,010
USD
|
|
2016-05-06 |
2016-05-05 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
38,247
-13.6%
105.00
4,015,935
USD
|
38,247
-13.6%
|
105.00
|
4,015,935
USD
|
|
2016-05-06 |
2016-05-05 |
PS
Planned sale
|
GOLD STEPHEN J
EVP & CIO
Officer
|
9,798
-31.2%
105.00
1,028,790
USD
|
9,798
-31.2%
|
105.00
|
1,028,790
USD
|
|
2016-05-06 |
2016-05-05 |
PS
Planned sale
|
Brennan Troyen A
EVP and Chief Medical Officer
Officer
|
7,517
-9.7%
105.00
789,285
USD
|
7,517
-9.7%
|
105.00
|
789,285
USD
|
|
2016-04-05 |
2016-04-01 |
PS
Planned sale
|
GOLD STEPHEN J
EVP & CIO
Officer
|
21,922
-52.1%
105.00
2,301,810
USD
|
21,922
-52.1%
|
105.00
|
2,301,810
USD
|
|
2016-04-05 |
2016-04-01 |
PS
Planned sale
|
Sussman Andrew
EVP & Pres, CVS MinuteClinic
Officer
|
2,844
-20.5%
105.00
298,620
USD
|
2,844
-20.5%
|
105.00
|
298,620
USD
|
|
2016-03-11 |
2016-03-09 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
38,247
-14.6%
100.00
3,824,700
USD
|
38,247
-14.6%
|
100.00
|
3,824,700
USD
|
|
2016-03-11 |
2016-03-09 |
PS
Planned sale
|
Brennan Troyen A
EVP, Chief Medical Officer
Officer
|
6,755
-8.8%
100.00
675,500
USD
|
6,755
-8.8%
|
100.00
|
675,500
USD
|
|
2016-02-11 |
2016-02-11 |
S
Sale
|
Roberts Jonathan C
EVP & President, CVS/caremark
Officer
|
23,355
-44.9%
92.86
2,168,745
USD
|
23,355
-44.9%
|
92.86
|
2,168,745
USD
|
|
2016-02-02 |
2016-02-01 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
46,393
-22.3%
96.14
4,460,010
USD
|
46,393
-22.3%
|
96.14
|
4,460,010
USD
|
|
2016-01-13 |
2016-01-11 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
46,393
-22.3%
95.00
4,407,335
USD
|
46,393
-22.3%
|
95.00
|
4,407,335
USD
|
|
2016-01-05 |
2016-01-04 |
PS
Planned sale
|
Finucane Anne A.
Non-Executive Director
|
2,000
-12.0%
95.87
191,749
USD
|
2,000
-12.0%
|
95.87
|
191,749
USD
|
|
2015-10-28 |
2015-10-27 |
PS
Planned sale
|
Brennan Troyen A
EVP, Chief Medical Officer
Officer
|
23,603
-27.6%
105.00
2,478,315
USD
|
23,603
-27.6%
|
105.00
|
2,478,315
USD
|
|
2015-07-21 |
2015-07-20 |
PS
Planned sale
|
Boratto Eva C
SVP, Cont & Chief Acct Officer
Officer
|
22,107
-47.6%
110.34
2,439,275
USD
|
22,107
-47.6%
|
110.34
|
2,439,275
USD
|
|
2015-07-16 |
2015-07-15 |
PS
Planned sale
|
Bisaccia Lisa
EVP, Chief HR Officer
Officer
|
12,058
-36.5%
110.00
1,326,380
USD
|
12,058
-36.5%
|
110.00
|
1,326,380
USD
|
|
2015-07-16 |
2015-07-15 |
PS
Planned sale
|
Bisaccia Lisa
EVP, Chief HR Officer
Officer
|
7,764
-27.0%
110.00
854,040
USD
|
7,764
-27.0%
|
110.00
|
854,040
USD
|
|
2015-07-16 |
2015-07-15 |
PS
Planned sale
|
Bisaccia Lisa
EVP, Chief HR Officer
Officer
|
8,392
-28.5%
110.00
923,120
USD
|
8,392
-28.5%
|
110.00
|
923,120
USD
|
|
2015-07-16 |
2015-07-15 |
PS
Planned sale
|
Bisaccia Lisa
EVP, Chief HR Officer
Officer
|
6,884
-24.7%
110.00
757,240
USD
|
6,884
-24.7%
|
110.00
|
757,240
USD
|
|
2015-07-16 |
2015-07-15 |
PS
Planned sale
|
Bisaccia Lisa
EVP, Chief HR Officer
Officer
|
6,884
-24.7%
110.01
757,309
USD
|
6,884
-24.7%
|
110.01
|
757,309
USD
|
|
2015-04-13 |
2015-04-10 |
PS
Planned sale
|
Sussman Andrew
EVP & Pres, CVS/minuteclinic
Officer
|
5,082
-36.4%
102.39
520,346
USD
|
5,082
-36.4%
|
102.39
|
520,346
USD
|
|
2015-04-13 |
2015-04-10 |
PS
Planned sale
|
Sussman Andrew
EVP & Pres, CVS/minuteclinic
Officer
|
6,655
-32.3%
102.38
681,339
USD
|
6,655
-32.3%
|
102.38
|
681,339
USD
|
|
2015-04-13 |
2015-04-10 |
PS
Planned sale
|
Sussman Andrew
EVP & Pres, CVS/minuteclinic
Officer
|
5,901
-29.7%
102.38
604,144
USD
|
5,901
-29.7%
|
102.38
|
604,144
USD
|
|
2015-04-03 |
2015-04-02 |
PS
Planned sale
|
Brennan Troyen A
EVP, Chief Medical Officer
Officer
|
16,637
-21.2%
102.71
1,708,786
USD
|
16,637
-21.2%
|
102.71
|
1,708,786
USD
|
|
2015-04-03 |
2015-04-01 |
PS
Planned sale
|
Brennan Troyen A
EVP, Chief Medical Officer
Officer
|
16,747
-22.6%
102.26
1,712,548
USD
|
16,747
-22.6%
|
102.26
|
1,712,548
USD
|
|
2015-03-24 |
2015-03-23 |
PS
Planned sale
|
Brennan Troyen A
EVP, Chief Medical Officer
Officer
|
33,274
-37.7%
104.94
3,491,774
USD
|
33,274
-37.7%
|
104.94
|
3,491,774
USD
|
|
2015-01-08 |
2015-01-07 |
PS
Planned sale
|
Roberts Jonathan C
EVP & President, CVS/caremark
Officer
|
86,487
-73.3%
95.31
8,243,076
USD
|
86,487
-73.3%
|
95.31
|
8,243,076
USD
|
|
2015-01-06 |
2015-01-05 |
PS
Planned sale
|
MERLO LARRY J
President and CEO
Executive Director
|
144,144
-65.4%
94.30
13,592,779
USD
|
144,144
-65.4%
|
94.30
|
13,592,779
USD
|
|
2015-01-05 |
2015-01-02 |
PS
Planned sale
|
Brennan Troyen A
EVP, Chief Medical Officer
Officer
|
50,240
-54.9%
95.71
4,808,516
USD
|
50,240
-54.9%
|
95.71
|
4,808,516
USD
|
|
2015-01-05 |
2015-01-02 |
PS
Planned sale
|
Lofberg Per GH
EVP
Officer
|
347,343
-93.7%
95.28
33,096,439
USD
|
347,343
-93.7%
|
95.28
|
33,096,439
USD
|
|
2014-11-10 |
2014-11-07 |
PS
Planned sale
|
Foulkes Helena
EVP, President-CVS/pharmacy
Officer
|
12,058
-40.0%
88.07
1,061,920
USD
|
12,058
-40.0%
|
88.07
|
1,061,920
USD
|
|
2014-11-10 |
2014-11-07 |
PS
Planned sale
|
Foulkes Helena
EVP, President-CVS/pharmacy
Officer
|
14,303
-44.2%
88.07
1,259,632
USD
|
14,303
-44.2%
|
88.07
|
1,259,632
USD
|
|
2014-11-10 |
2014-11-07 |
PS
Planned sale
|
Foulkes Helena
EVP, President-CVS/pharmacy
Officer
|
19,964
-52.5%
88.06
1,758,032
USD
|
19,964
-52.5%
|
88.06
|
1,758,032
USD
|
|
2014-10-28 |
2014-10-27 |
PS
Planned sale
|
Bisaccia Lisa
SVP, Chief HR Officer
Officer
|
5,921
-25.5%
85.00
503,285
USD
|
5,921
-25.5%
|
85.00
|
503,285
USD
|
|
2014-10-28 |
2014-10-27 |
PS
Planned sale
|
Bisaccia Lisa
SVP, Chief HR Officer
Officer
|
12,058
-34.2%
85.00
1,024,930
USD
|
12,058
-34.2%
|
85.00
|
1,024,930
USD
|
|
2014-10-28 |
2014-10-27 |
PS
Planned sale
|
Bisaccia Lisa
SVP, Chief HR Officer
Officer
|
15,528
-40.1%
85.00
1,319,880
USD
|
15,528
-40.1%
|
85.00
|
1,319,880
USD
|
|
2014-09-03 |
2014-09-02 |
PS
Planned sale
|
Sussman Andrew
SVP & President, MinuteClinic
Officer
|
9,020
-56.2%
79.45
716,639
USD
|
9,020
-56.2%
|
79.45
|
716,639
USD
|
|
2014-08-07 |
2014-08-06 |
PS
Planned sale
|
Joyner J. David
EVP, Sales & Account Services
Officer
|
45,897
-50.3%
76.10
3,492,762
USD
|
45,897
-50.3%
|
76.10
|
3,492,762
USD
|
|
2014-08-07 |
2014-08-06 |
PS
Planned sale
|
Joyner J. David
EVP, Sales & Account Services
Officer
|
77,619
-63.1%
76.10
5,906,806
USD
|
77,619
-63.1%
|
76.10
|
5,906,806
USD
|
|
2014-07-22 |
2014-07-21 |
PS
Planned sale
|
Boratto Eva C
SVP, Cont & Chief Acct Officer
Officer
|
22,107
-55.4%
76.77
1,697,154
USD
|
22,107
-55.4%
|
76.77
|
1,697,154
USD
|
|
2014-07-03 |
2014-07-01 |
PS
Planned sale
|
Denton David M
EVP, CFO
Officer
|
74,989
-46.3%
75.88
5,690,165
USD
|
74,989
-46.3%
|
75.88
|
5,690,165
USD
|
|
2014-04-03 |
2014-04-02 |
PS
Planned sale
|
Boratto Eva C
SVP, Cont & Chief Acct Officer
Officer
|
4,425
-20.0%
74.51
329,707
USD
|
4,425
-20.0%
|
74.51
|
329,707
USD
|
|
2014-04-03 |
2014-04-02 |
PS
Planned sale
|
Boratto Eva C
SVP, Cont & Chief Acct Officer
Officer
|
6,029
-25.4%
74.51
449,221
USD
|
6,029
-25.4%
|
74.51
|
449,221
USD
|
|
2014-04-03 |
2014-04-02 |
PS
Planned sale
|
Boratto Eva C
SVP, Cont & Chief Acct Officer
Officer
|
6,654
-27.3%
74.51
495,790
USD
|
6,654
-27.3%
|
74.51
|
495,790
USD
|
|